Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancerX Pivot, A Awada, D Gedouin, et al.
Cancer Chemotherapy and Pharmacology|May 19, 2010
Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumorsF Caponigro, D Lorusso, G Fornari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Phase II study of E7070 in patients with metastatic melanomaJ F Smyth, S Aamdal, A Awada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancerF Caponigro, A Avallone, H McLeod, et al.
Breast Cancer Research and Treatment|August 7, 1998
Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II studyG Frasci, P Comella, G D'Aiuto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2002
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancerM M Borner, P Schoffski, R de Wit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase CD J Propper, A C McDonald, A Man, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckP Bossi, R Miceli, L D Locati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2016
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trialP M Clement, T Gauler, J P Machiels, et al.
Pageof 5